home / stock / azrx / azrx news

AZRX News and Press, AzurRx BioPharma Inc. From 11/30/20

Stock Information
Company Name: AzurRx BioPharma Inc.
Stock Symbol: AZRX
Market: NASDAQ
Website: azurrx.com
Menu
AZRX AZRX Quote AZRX Short AZRX News AZRX Articles AZRX Message Board
Get AZRX Alerts

News, Short Squeeze, Breakout and More Instantly...
AZRX - AzurRx up 9% on advancement of mid-stage study of MS1819 in CF patients

Thinly traded nano cap AzurRx BioPharma (AZRX) perks up 9% premarket on light volume in reaction to the commencement of dosing in Turkey in an open-label Phase 2 clinical trial evaluating MS1819, combined with standard-of-care [porcine -derived pancreatic enzyme replacement therapy ...
AZRX - AzurRx BioPharma Announces First Patients Dosed in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

Patient screening and dosing ongoing in Turkey and Hungary Topline data expected in Q2 2021 for the Combination Trial DELRAY BEACH, Fla., Nov. 30, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a c...

AZRX - InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein

LOS ANGELES, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episod...

AZRX - AzurRx BioPharma Requests Protocol Amendment to Phase 2b OPTION 2 Study of MS1819 in Cystic Fibrosis Patients

Potential to add additional study arm utilizing immediate release capsules Trial objectives, endpoints and statistical analysis to remain the same DELRAY BEACH, Fla., Nov. 17, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...
AZRX - AzurRx BioPharma Identifies Asymchem as Potential Partner of Choice for MS1819 Phase 3 Clinical Trial Drug Production

DELRAY BEACH, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that ...

AZRX - AzurRx BioPharma Provides Insight into Drawbacks of Using Porcine Products in Production of Pharmaceuticals and Medicinals, Offers Update on Efforts to Produce Synthetic Alternatives

NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- AzurRx BioPharma, Inc. ( NASDAQ: AZRX ) (“AzurRx” or the “Company”), a New York-based biopharmaceutical company specializing in the development of therapeutic proteins for...

AZRX - AzurRx BioPharma Announces Formation of Scientific Advisory Board

Globally recognized experts in cystic fibrosis and chronic pancreatitis care and research to support AzurRx in advancing the clinical development of MS1819 NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) --  AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “...
AZRX - AzurRx Bio activates additional trial sites for lead candidate

AzurRx BioPharma ([[AZRX]]) has activated two trial sites in Turkey for its Phase 2 trial, evaluating MS1819 combined with porcine pancreatic enzyme replacement therapy ((PERT)), in cystic fibrosis ((CF)) patients with severe exocrine pancreatic insufficiency ((EPI))....

AZRX - AzurRx BioPharma Activates Additional Clinical Trial Sites in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis

Two clinical trial sites activated in Turkey, with patient screening initiated Follows activation of six clinical sites in Hungary and dosing of first eight patients Topline data expected in Q2 2021 NEW YORK, Oct. 14, 2020 (GLOBE NEWSWIRE)...

AZRX - AzurRx BioPharma Announces Two Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference

Abstracts to Focus on: Results from Phase 2, Open-Label, Multicenter, 2x2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in Patients with Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis & Best Enteric Capsule for Targeted Duodenal Delivery of Non-Porcine ...
Previous 10 Next 10